BIOMAT Database Logo BIOMAT Database Logo

A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. 1991

A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Division of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Canada.

Malignant hyperthermia (MH) is currently diagnosed by the caffeine-halothane contracture (CHC) test. In a previous study, this test was used to establish linkage between the human gene for MH susceptibility and the ryanodine receptor (RYR) gene. The current study extends the genetic linkage analysis to a large French-Canadian kindred. In this family, genetic linkage between RYR and MH genes was not demonstrable using the currently recommended limits of normal for the CHC test in the identification of MH-susceptible individuals. With CHC test threshold limits below those currently recommended, however, complete linkage between the RYR and MH genes was seen. Comparisons of CHC test results with genetic linkage studies will increase the diagnostic accuracy of both tests as well as generate new insights into the biology of MH.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D008305 Malignant Hyperthermia Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia. Hyperpyrexia, Malignant,Hyperthermia, Malignant,Malignant Hyperpyrexia,Anesthesia Related Hyperthermia,Hyperthermia of Anesthesia,Anesthesia Hyperthermia,Hyperthermia, Anesthesia Related,Malignant Hyperpyrexias
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome

Related Publications

A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
[Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia].
April 2008, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
October 1989, Anesthesia and analgesia,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
November 1982, Canadian Anaesthetists' Society journal,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
June 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.
July 1993, Anesthesiology,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
December 1987, British journal of anaesthesia,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.
January 1996, Journal of medical genetics,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Combined caffeine-halothane test for malignant hyperthermia.
May 1993, British journal of anaesthesia,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
April 1996, Acta anaesthesiologica Scandinavica,
A E MacKenzie, and G Allen, and D Lahey, and M L Crossan, and K Nolan, and G Mettler, and R G Worton, and D H MacLennan, and R Korneluk
Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone.
April 1994, Anesthesia and analgesia,
Copied contents to your clipboard!